Duke of Edinburgh becomes fellow of Royal Society of Edinburgh
He was given the honour in recognition of his long-standing public service and commitment to creating opportunities for young people.
The Duke is patron of more than 70 charities and organisations across the arts, sport and education, including Northern Ballet, the British Paralympic Association, the National Youth Theatre, and the National Youth Orchestras of Scotland.
He also leads The Duke of Edinburgh's International Award Foundation, where he has served as chairman of trustees since 2015.
The Duke, who was in Scotland during royal week, was inducted by the Royal Society of Edinburgh (RSE) president, Professor Sir Anton Muscatelli.
In his address to the RSE Fellows and members of the Young Academy of Scotland on Thursday, the Duke said: 'I thank the Fellows of The Royal Society of Edinburgh for this great honour of inducting me into your society to join your ranks.
'I am proud to join and recognise this institution's rich history and its unwavering commitment to the advancement of knowledge for good, and it has been wonderful to learn about the breadth of this work today.'
The RSE, which has more than 1,800 fellows, supports, and mobilises expertise from across academia, business, and public service for the benefit of Scotland and the wider world.
Professor Sir Anton Muscatelli said: 'His Royal Highness has demonstrated a lifelong commitment to the health and happiness of young people across such a wide range of areas of our society and latterly has taken on the leadership of the Duke of Edinburgh's International Award Foundation.
'Today's celebration continues an unbroken and vital connection between Scotland's National Academy and the Royal Family, one which I am deeply proud to pay tribute to today.'
After his own induction the Duke presented an RSE Royal Medal to Professor Peter Kennedy, Burton Chair of Neurology at the University of Glasgow.
Edward is also Honorary Senior Research Fellow in the Institute of Infection, Immunity, and Inflammation at the University of Glasgow.
The Royal Medal is the RSE's highest recognition of achievement with only 52 having been presented since their inception in 2000.
Professor Kennedy was awarded the medal for his contribution in distinguishing the major human brain cell types, paving the way to significant diseases and infections, as well as identification of a novel therapy for African trypanosomiasis, known as sleeping sickness.
The Duke of Edinburgh said he is 'delighted' that the society has recognised the work of Prof Kennedy.
He said: 'It is a great honour and privilege to be able to present him a RSE Royal Medal in recognition of his important work.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Times
12 hours ago
- Times
Scientists' discovery could stop breast cancer spreading
Scottish scientists have made a discovery that could help stop breast cancer spreading to other parts of the body. Experts at Cancer Research UK Scotland Institute and the University of Glasgow have found there are key metabolic changes that take place before tumours grow elsewhere. Their work is being hailed as a significant breakthrough because it is often cancer moving from the breast that kills patients. • How I told my sons that I had a rare form of breast cancer Researchers writing in the journal EMBO Reports said identifying the metabolic changes offered a vital window to intervene. Detecting these changes early could allow therapies to stop cancer cells moving around the body and forming tumours elsewhere. Dr Cassie Clarke, lead researcher, said: 'This study represents a major shift in how we think about preventing the spread of breast cancer. By targeting these metabolic changes as early as possible we could stop the cancer progressing and save lives.' About 56,800 people are diagnosed with breast cancer in the United Kingdom each year and 11,300 people lose their lives to the disease. Dr Catherine Elliott, Cancer Research UK's director of research, said: 'Discoveries in cancer research have made huge strides in making breast cancer a far more treatable disease than ever before. • Why the way we diagnose, label and treat cancer is changing 'However, metastasis — when cancer spreads — is a major factor in breast cancer becoming harder to treat, especially if the cancer returns months or even many years later. 'This discovery gives us new hope for detecting and stopping metastasis early and ensuring people have many more years with their families and loved ones.' The study focused on how breast cancer changes the immune system so it cannot tackle cancer cells as they begin their spread. The researchers found that cancer changes the metabolism — the way cells make and use energy — of specific immune cells, resulting in them releasing a prominent metabolite called uracil. Uracil is a molecule key to essential processes in the body which was found to help distant organs build a 'scaffold' to grow secondary tumours elsewhere in the body. By blocking an enzyme called uridine phosphorylase-1 (UPP1), which produces uracil, the scientists were able to stop this scaffold forming in mice and restore the ability of the immune system to kill secondary cancer cells to prevent metastasis. This opens the door to potentially powerful new tools to tackle cancer. Detecting uracil in the blood could help spot early signs of cancer spread, while blocking UPP1 with drugs could stop the spread before it starts. • The Times View: It is time to be optimistic about cancer The research was funded by Cancer Research UK, the Wellcome Trust, the Medical Research Council, Breast Cancer Now and Pancreatic Cancer UK. Simon Vincent, chief scientific officer at Breast Cancer Now, said: 'The researchers discovered that high levels of a protein called UPP1 may make some cancers, including breast cancer, more likely to spread to other parts of the body, where the disease becomes incurable. 'In mice, targeting the UPP1 protein before secondary breast cancer developed led to fewer secondary breast tumours and a boosted immune response in the lungs. 'Now we need more research to see if this new insight can be turned into new drugs that stop secondary breast cancer, and potentially other secondary cancers, in their tracks. With around 61,000 people living with secondary breast cancer in the UK, research like this is vital.' The team are further investigating exactly how UPP1 changes the behaviour of immune cells, exploring the role of immune cell metabolism in early breast cancer initiation, and testing the ability of drugs that block immune cell metabolism to prevent cancer occurring.
Economist
4 days ago
- Economist
The pandemic preparedness dividend—investing today to prevent and mitigate tomorrow's pandemics
Announcing the Africa Health Security Index The world remains dangerously unprepared for the next biological threat. The 2021 Global Health Security (GHS) Index gave African nations an average score of 29 out of a possible 100, which leaves significant room for improvement. The Africa Health Security (AHS) Index is a comprehensive, independent assessment of epidemic and pandemic preparedness across Africa. The AHS Index is developed by NTI | bio, in partnership with the Brown University Pandemic Center and Economist Impact, in collaboration with Science for Africa Foundation, the University of the Witwatersrand (Johannesburg, South Africa) and the University of Tunis El Manar (Tunis, Tunisia). Funding is provided by the Gates Foundation. The index, launching in 2026, will enable leaders to measure, finance and advance improvements in health security and create an evidence-based accountability framework to track progress towards better epidemic and pandemic preparedness in Africa.
Economist
4 days ago
- Economist
Rethinking the war on AIDS
AIDS AND HIV, the virus that causes it, once sparked fear across the world. Apocalyptic forecasters in early 2002 reckoned that in some southern African countries half of new mothers would soon die of AIDS. Tens of millions of lives would be lost over coming decades. Economies would be devastated. Instead, what was arguably the most effective foreign-aid programme ever was introduced in 2003 by President George W. Bush.
